"the lung" trang 11 - tải miễn phí từ tailieunhanh
High expression of AGR2 in lung cancer is predictive of poor survival

High expression of AGR2 in lung cancer is predictive of poor survival
9    22    1
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients
10    50    1
UBR-box containing protein, UBR5, is overexpressed in human lung adenocarcinoma and is a potential therapeutic target

UBR-box containing protein, UBR5, is overexpressed in human lung adenocarcinoma and is a potential therapeutic target
12    32    1
Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer

Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
10    36    1
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer
8    34    1
Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients

Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients
6    56    1
Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer
7    40    1
Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity

Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity
9    36    1
The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: A meta-analysis

The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: A meta-analysis
9    73    1
AHRR methylation in heavy smokers: Associations with smoking, lung cancer risk, and lung cancer mortality

AHRR methylation in heavy smokers: Associations with smoking, lung cancer risk, and lung cancer mortality
10    44    1
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer
10    50    1
A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung

A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
4    50    1
Pattern of use of radiotherapy for lung cancer: A descriptive study

Pattern of use of radiotherapy for lung cancer: A descriptive study
8    42    1
Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer

Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
7    34    1
Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines

Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines
9    47    1
Osteopontin is a prognostic biomarker in non-small cell lung cancer

Osteopontin is a prognostic biomarker in non-small cell lung cancer
10    69    1
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
10    57    1
VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma

VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma
7    37    1
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
5    36    1
Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancerrelated gene

Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancerrelated gene
11    75    1